Xiao‐Ning Xu

5.0k total citations · 1 hit paper
55 papers, 3.1k citations indexed

About

Xiao‐Ning Xu is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Xiao‐Ning Xu has authored 55 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 17 papers in Virology and 14 papers in Epidemiology. Recurrent topics in Xiao‐Ning Xu's work include Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (19 papers) and HIV Research and Treatment (17 papers). Xiao‐Ning Xu is often cited by papers focused on Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (19 papers) and HIV Research and Treatment (17 papers). Xiao‐Ning Xu collaborates with scholars based in United Kingdom, China and United States. Xiao‐Ning Xu's co-authors include Gavin Screaton, Andrew J. McMichael, Tao Dong, Juthathip Mongkolsapaya, Wanwisa Dejnirattisai, Prida Malasit, Thaneeya Duangchinda, Sarah Rowland‐Jones, Demin Li and Nattaya Tangthawornchaikul and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Xiao‐Ning Xu

54 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever

2003 633 citations Juthathip Mongkolsapaya, Wanwisa Dejnirattisai et al. profile →

Peers

Countries citing papers authored by Xiao‐Ning Xu

Since Specialization

Citations

This map shows the geographic impact of Xiao‐Ning Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Ning Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Ning Xu more than expected).

Fields of papers citing papers by Xiao‐Ning Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Ning Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Ning Xu. The network helps show where Xiao‐Ning Xu may publish in the future.

Co-authorship network of co-authors of Xiao‐Ning Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Ning Xu. A scholar is included among the top collaborators of Xiao‐Ning Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Ning Xu. Xiao‐Ning Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HLA-E–restricted, Gag-specific CD8 ⁺ T cells can suppress HIV-1 infection, offering vaccine opportunities 2021 ·Science Immunology ·Hongbing Yang, Margarida Rei, Simon Brackenridge, (unknown), Hong Sun, Shaheed Abdulhaqq, Michael K. P. Liu, Weiwei Ma, Prathiba Kurupati, Xiao‐Ning Xu, Vincenzo Cerundolo, Edward Jenkins, Simon J. Davis, Jonah B. Sacha, Klaus Früh, Louis J. Picker, Persephone Borrow, Geraldine M. Gillespie, Andrew J. McMichael	34
2	Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly 2020 ·Frontiers in Immunology ·Branca Pereira, Xiao‐Ning Xu, Arne N. Akbar	106
3	Association of RASSF1A Promoter Methylation with Lung Cancer Risk: a Meta-analysis 2015 ·Asian Pacific Journal of Cancer Prevention ·(unknown), Wei Wu, Kun Wu, Xiao‐Ning Xu, Wenru Tang	10
4	HLA-B44 Is Associated with a Lower Viral Set Point and Slow CD4 Decline in a Cohort of Chinese Homosexual Men Acutely Infected with HIV-1 2013 ·Clinical and Vaccine Immunology* ·Xin Zhang, Xiaojie Huang, Wei Xia, Weihua Li, Tong Zhang, Hao Wu, Xiao‐Ning Xu, Huiping Yan	11
5	Epidemiology of Group B Streptococcus in developing countries 2013 ·Vaccine ·Atul Kumar Johri, Hem Lata, Puja Yadav, Meenakshi Dua, Yonghong Yang, Xiao‐Ning Xu, Akira Homma, Michèle A. Barocchi, Matthew J. Bottomley, Allan Saul, Keith P. Klugman, Steven Black	43
6	Correlates of protection against influenza infection in humans — on the path to a universal vaccine? 2013 ·Current Opinion in Immunology ·(unknown), Rino Rappuoli, Xiao‐Ning Xu	38
7	Plasma IP-10 Is Associated with Rapid Disease Progression in Early HIV-1 Infection 2012 ·Viral Immunology ·Yanmei Jiao, Tong Zhang, Rui Wang, (unknown), Xiaojie Huang, Jiming Yin, Liguo Zhang, Xiao‐Ning Xu, Hao Wu	67
8	Rate of CD4 Decline and HIV-RNA Change Following HIV Seroconversion in Men Who Have Sex With Men 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Xiaojie Huang, Sara Lodi, Zoë Fox, Wei Li, Andrew Phillips, Kholoud Porter, Irja Lutsar, Anthony D. Kelleher, Ning Li, Xiao‐Ning Xu, Hao Wu, Margaret Johnson	41
9	Precise Determination of Time to Reach Viral Load Set Point After Acute HIV-1 Infection 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Xiaojie Huang, Hui Chen, Wei Li, Haiying Li, Xia Jin, Alan S. Perelson, Zoë Fox, Tong Zhang, Xiao‐Ning Xu, Hao Wu	24
10	Ig-Like Transcript 4 Inhibits Lipid Antigen Presentation through Direct CD1d Interaction 2009 ·The Journal of Immunology ·Demin Li, Lili Wang, Li Yu, Eric C. Freundt, Boquan Jin, Gavin Screaton, Xiao‐Ning Xu	37
11	Human CD4+ Memory T Cells Are Preferential Targets for Bystander Activation and Apoptosis 2009 ·The Journal of Immunology ·(unknown), Dilair Baban, Helen Cattan, (unknown), Andrew J. McMichael, Xiao‐Ning Xu	39
12	Lower cellular immune responses to influenza A (H3N2) in the elderly 2009 ·Journal of Medical Virology ·Na Jia, Chris Li, Yunxi Liu, Jan Hendrik Richardus, Dan Feng, Hong Yang, (unknown), Yonghong Ma, Xiao‐Ning Xu, Wu‐Chun Cao	7
13	A single amino acid defines cross‐species reactivity of tree shrew (Tupaia belangeri) CD1d to human invariant natural killer T (iNKT) cells 2009 ·Immunology ·Ping Zhang, Demin Li, Guillaume B. E. Stewart-Jones, (unknown), (unknown), Qiongyu Chen, (unknown), You‐Wen He, Xiao‐Ning Xu, (unknown)	3
14	A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung 2007 ·The Journal of Experimental Medicine ·Yongxiong Chen, Vera Chan, Bo‐Jian Zheng, Kelvin Y.K. Chan, Xiao‐Ning Xu, (unknown), (unknown), US Khoo, (unknown)	37
15	T Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal? 2006 ·The Journal of Immunology ·Juthathip Mongkolsapaya, Thaneeya Duangchinda, Wanwisa Dejnirattisai, (unknown), Panisadee Avirutnan, (unknown), (unknown), Nattaya Tangthawornchaikul, Pojchong Chotiyarnwong, (unknown), Michael Koch, E. Yvonne Jones, Andrew J. McMichael, Xiao‐Ning Xu, Prida Malasit, Gavin Screaton	207
16	HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis 2005 ·Proceedings of the National Academy of Sciences ·Hal Drakesmith, Nan Chen, (unknown), Gavin Screaton, Alain Townsend, Xiao‐Ning Xu	69
17	HIV‐1 down‐regulates the expression of CD1d via Nef 2005 ·European Journal of Immunology ·Nan Chen, Corinna McCarthy, Hal Drakesmith, Demin Li, Vincenzo Cerundolo, Andrew J. McMichael, Gavin Screaton, Xiao‐Ning Xu	104
18	HIV-specific Cytotoxic T Cells from Long-Term Survivors Select a Unique T Cell Receptor 2004 ·The Journal of Experimental Medicine ·Tao Dong, Guillaume Stewart-Jones, Nan Chen, Philippa Easterbrook, Xiao‐Ning Xu, Laura Papagno, Victor Appay, Michael P. Weekes, Chris Conlon, Celsa A. Spina, Susan J. Little, Gavin Screaton, Anton van der Merwe, Douglas D. Richman, Andrew J. McMichael, E. Yvonne Jones, Sarah Rowland‐Jones	91
19	MHC/peptide tetramer-based studies of T cell function 2002 ·Journal of Immunological Methods ·Xiao‐Ning Xu, Gavin Screaton	28
20	Cutting Edge: Lymphocyte Inhibitor of TRAIL (TNF-Related Apoptosis-Inducing Ligand): A New Receptor Protecting Lymphocytes from the Death Ligand TRAIL 1998 ·The Journal of Immunology ·Juthathip Mongkolsapaya, Alison E. Cowper, Xiao‐Ning Xu, Gwilym M. Morris, Andrew J. McMichael, John I. Bell, Gavin Screaton	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact